The sell off will be brutal if it relists again imo. Nasdaq investors did their due diligence and gave it the almighty thumbs down. Cash in bank must be almost depleted imo, and with no production forecast in the near future in that shiny new CFDA approved facility in China, one has to ask where the money will come from for all the overheads to be paid.
This truly is a dead horse, having had so many false starts it's no wonder it's under suspension.
AIMO
- Forums
- ASX - By Stock
- GMV
- Ann: Response to ASX Query
Ann: Response to ASX Query, page-154
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online